We are live on ! Find out more
MGP

Metis Global Partners Portfolio holdings

AUM $4.07B
1-Year Est. Return 30.82%
This Fund
S&P 500
This Quarter Est. Return
-1.33%
1 Year Est. Return
+30.82%
3 Year Est. Return
+100.28%
5 Year Est. Return
10 Year Est. Return
AUM
$3.56B
AUM Growth
+$238M
Cap. Flow
+$365M
Cap. Flow %
10.27%
Top 10 Hldgs %
33.36%
Holding
816
New
27
Increased
643
Reduced
72
Closed
27

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$20.1M
2
NVDA icon
NVIDIA
NVDA
+$19.7M
3
MSFT icon
Microsoft
MSFT
+$18.4M
4
AMZN icon
Amazon
AMZN
+$13.2M
5
EWJ icon
iShares MSCI Japan ETF
EWJ
+$9.94M

Sector Composition

Rank Sector Weight
1 Technology 26.78%
2 Financials 12.42%
3 Healthcare 9.34%
4 Consumer Discretionary 9.01%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLTR icon
76
Palantir
PLTR
$295B
$8M 0.23%
94,792
+17,619
+23% +$1.55M
MRSH
77
Marsh
MRSH
$90.5B
$7.99M 0.22%
32,751
+3,519
+12% +$798K
DUK icon
78
Duke Energy
DUK
$97.8B
$7.98M 0.22%
65,420
+7,521
+13% +$857K
SCHW
79
Charles Schwab
SCHW
$183B
$7.91M 0.22%
101,018
+19,726
+24% +$1.55M
PSA icon
80
Public Storage
PSA
$60.5B
$7.86M 0.22%
26,274
+2,923
+13% +$874K
UNP icon
81
Union Pacific
UNP
$174B
$7.84M 0.22%
33,166
+5,195
+19% +$1.25M
GILD icon
82
Gilead Sciences
GILD
$162B
$7.65M 0.22%
68,255
+7,244
+12% +$747K
UBER icon
83
Uber
UBER
$143B
$7.65M 0.22%
104,935
+14,444
+16% +$1.04M
VRTX icon
84
Vertex Pharmaceuticals
VRTX
$121B
$7.61M 0.21%
15,699
+1,814
+13% +$845K
BMY icon
85
Bristol-Myers Squibb
BMY
$133B
$7.48M 0.21%
122,725
+16,222
+15% +$946K
BSX icon
86
Boston Scientific
BSX
$69.5B
$7.37M 0.21%
73,058
+11,106
+18% +$1.12M
BKNG icon
87
Booking.com
BKNG
$149B
$7.34M 0.21%
39,825
+5,325
+15% +$1.02M
SYK icon
88
Stryker
SYK
$125B
$7.22M 0.2%
19,397
+2,556
+15% +$973K
NTR icon
89
Nutrien
NTR
$33.2B
$7.2M 0.2%
144,981
+1,424
+1% +$72.9K
ADP icon
90
Automatic Data Processing
ADP
$106B
$7.17M 0.2%
23,478
+1,843
+9% +$556K
COP icon
91
ConocoPhillips
COP
$147B
$7.15M 0.2%
68,039
+11,103
+20% +$1.11M
MS icon
92
Morgan Stanley
MS
$331B
$7.01M 0.2%
60,088
+6,737
+13% +$868K
ADI icon
93
Analog Devices
ADI
$179B
$7.01M 0.2%
34,738
+4,542
+15% +$982K
MCO icon
94
Moody's
MCO
$82.8B
$7M 0.2%
15,041
+1,594
+12% +$768K
AMAT icon
95
Applied Materials
AMAT
$403B
$6.99M 0.2%
48,189
+3,937
+9% +$662K
AVB icon
96
AvalonBay Communities
AVB
$26.5B
$6.98M 0.2%
32,507
+3,532
+12% +$767K
HON icon
97
Honeywell
HON
$77B
$6.89M 0.19%
34,545
+4,349
+14% +$880K
RY icon
98
Royal Bank of Canada
RY
$291B
$6.89M 0.19%
61,143
-2,850
-4% -$336K
XYL icon
99
Xylem
XYL
$27.3B
$6.75M 0.19%
56,482
+5,906
+12% +$732K
C icon
100
Citigroup
C
$222B
$6.54M 0.18%
92,148
+11,165
+14% +$851K

Similar funds

Metis Global Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Metis Global Partners held 816 positions worth $3.56B, up 7.2% from $3.32B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Metis Global Partners deployed $365M of net new capital in Q1 2025, opening 27 new positions and adding to 643 existing holdings. Its largest new stake was iShares MSCI Japan ETF: 144,537 shares worth $9.91M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was abrdn Physical Gold Shares ETF, an estimated $4.76M trimmed.

  • Metis Global Partners's largest Q1 2025 buy was iShares MSCI Japan ETF: 144,537 shares worth $9.91M.
  • Metis Global Partners added most to Apple in Q1 2025, an estimated $20.1M increase.
  • Metis Global Partners's biggest Q1 2025 reduction was abrdn Physical Gold Shares ETF, cutting an estimated $4.76M.
  • Metis Global Partners fully exited Enphase Energy in Q1 2025, selling an estimated $1.71M.
  • Metis Global Partners's ten largest holdings make up 33% of its $3.56B portfolio in Q1 2025.
  • Metis Global Partners opened 27 new positions and closed 27 in Q1 2025.
  • Metis Global Partners's portfolio value rose 7.2% quarter-over-quarter to $3.56B.

Based on Metis Global Partners's 13F filing for Q1 2025, filed 7 May 2025.